Masakazu Katoh

Title: Masakazu Katoh: Innovator in Bone Metabolism Treatments

Introduction

Masakazu Katoh is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical compositions aimed at treating metabolic bone diseases. With a total of 3 patents to his name, Katoh's work focuses on innovative methods that enhance bone health.

Latest Patents

One of Katoh's latest patents is a method of treating metabolic bone diseases using an IL-1 receptor. This method involves a pharmaceutical composition that includes IL-1 receptor or a soluble fragment derived from mammals. The composition is designed to inhibit bone resorption, making it useful for both therapy and prophylaxis of metabolic bone diseases. Another notable patent is for pharmaceutical compositions of benzopyranes that inhibit bone resorption. These compositions contain a pharmaceutical carrier and a therapeutically effective amount of a benzopyran derivative, which is beneficial for treating and preventing diseases associated with bone metabolism.

Career Highlights

Throughout his career, Masakazu Katoh has worked with notable companies such as Hoechst Japan Limited and Hoechst Aktiengesellschaft. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Katoh has collaborated with several professionals in his field, including Ryoichi Satoh and Denis Carniato. These collaborations have likely enriched his research and development efforts.

Conclusion

Masakazu Katoh's innovative work in the treatment of metabolic bone diseases showcases his dedication to advancing medical science. His patents reflect a commitment to improving patient outcomes through effective pharmaceutical solutions.